Purification and mechanism of action of "cortexin," a novel antihypertensive protein hormone from kidney and its role in essential hypertension in men

Journal of the American Society of Hypertension

Volumn 3, Issue 2, 2009, Pages 119-132

  Chakraborty, Somashree ^a   Khan, Gausal A ^a   Karmohapatra, Soumendra K ^a   Bhattacharya, Rabindra ^b   Bhattacharya, Gorachand ^c   Sinha, A Kumar ^a  

^a Sinha Institute of Medical Science and Technology   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

Author keywords

cAMP; cGMP; Endothelial cells; endothelial nitric oxide synthase

Indexed keywords

CORTEXIN; KIDNEY HORMONE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG PURIFICATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 62549131768     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.11.002     Document Type: Article

References (32)

1. Messerli F.H., Williams B., and Ritz E. Essential hypertension. Lancet 370 (2007) 591-603
2. Vasan R.S., Larson M.G., Leip E.P., Evans J.C., O'Donnell C.J., Kannel W.B., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345 (2001) 1291-1297
3. Furman M.I., Benoit S.E., Bernard M.R., Valeri C.R., Borbone M.L., Becker R.C., et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31 (1998) 352-358
4. Ignarro L.J., Harbison R.G., Wood K.S., and Kadowitz P.J. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 237 (1986) 893-900
5. Vural P., Cevik A., Curgunlu A., and Canbaz M. Effects of diabetes mellitus and acute hypertension on plasma nitric oxide and endothelin concentrations in rats. Clin Chim Acta 320 (2002) 43-47
6. Kanowitz P.J. Evidence for the inhibitory role of guanosine 3,5,-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57 (1981) 946-955
7. Ridao N., Luño J., Garcia de Vinuesa S., Gomez F., Tejedor A., and Valderrábano F. Prevalence of hypertension in renal disease. Nephrol Dial Transplant 16 (2001) S70-S73
8. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294 (2007) F1-F9
9. Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. Harrison's principles of international medicine. Vol. II. 16th ed (2005), McGraw-Hill Medical Publishing Division, New York, New York A1-A15
10. Guha M., Biswas J., Tirkey J., and Sinha A.K. Impairment of stimulation by estrogen of insulin-activated nitric oxide synthase in human breast cancer. Int J Cancer 100 (2002) 261-265
11. Dutta-Roy A.K., and Sinha A.K. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. J Biol Chem 262 (1987) 12685-12691
12. 4. Nature 27 (1970) 680-685
13. Hochstrasser D.F., Patchornik A., and Merril C.R. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 173 (1988) 412-423
14. Ling V., Guzetta A.W., Canova-Davis E., Stults J.T., and Hancock W.S. Characterization of the tryptic map of recombinant DNA derived tissue plasminogen activator by high-performance liquid chromatography-electrospray ionization mass spectrometry. Anal Chem 63 (1991) 2909-2915
15. Pickering T.G., Hall J.E., Appel L.J., Falkner B.E., Graves J., Hill M.N., et al. Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45 (2005) 142-161
16. Sinha A.K., Bhattacharya S., Acharya K., and Majumder S. Stimulation of nitric oxide synthesis and protective role of insulin in acute thrombosis in vivo. Life Sci 65 (1999) 2687-2696
17. Jia L., Bonaventura C., Bonaventura J., and Stamler S.J. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380 (1996) 221-226
18. Cox R.D., and Frank C.W. Determination of nitrate and nitrite in blood and urine by chemiluminescence. J Anal Toxicol 6 (1982) 148-152
19. Tlaskalova-Hogenova H., and Stepankova R. Development of antibody formation in germ-free and conventionally reared rabbits: the role of intestinal lymphoid tissue in antibody formation to E. coli antigens. Folia Biol (Praha) 26 (1980) 81-93
20. Engvall E., and Perlman P. Enzyme-linked immunosorbent assay, ELISA. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 109 (1972) 129-135
21. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 262 (1987) 10035-10038
22. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. NIH. Current protocol in immunology, Vol 1, Section 5.8., Wiley Interscience, New York, 1991.
23. Baelde H.J., Cleton-Jansen A.M., van Beerendonk H., Namba M., Bovee J.V., and Hogendoorn P.C. High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol 54 (2001) 778-782
24. Zimmerman R., Paluch U., Sprinzl M., and Neupert W. Cell-free synthesis of the mitochondrial ADP/ATP carrier protein of Neurospora crassa. Eur J Biochem 99 (1979) 247-252
25. Gilman A.G. Protein binding assays for cyclic nucleotides. Adv Cyclic Nucleotide Res 2 (1972) 9-24
26. Chakraborty K., Khan G.A., Banerjee P., Ray U., and Sinha A.K. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Platelets 14 (2003) 421-427
27. Vila-Petroff M.G., Younes A., Egan J., Lakatta E.G., and Sollott S.J. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84 (1999) 1020-1031
28. Sakuma I., Stuehr D.J., Gross S.S., Nathan C., and Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85 (1988) 8664-8667
29. Lorenzo Fernández P., Mediavilla A., Moreno A., Catrillo M., and Lorenzo-Velazquez B. Pharmacological aspects of sodium nitroprusside. Arch Inst Farmacol Exp (Madr) 23 (1971) 1-51
30. Karsten A.J., Derouet H., Ziegler M., and Eckert R.E. Involvement of cyclic nucleotides in renal artery smooth muscle relaxation. Urol Res 30 (2003) 367-373
31. Bhattacharya S., Chakraborty Patra S., Basu Roy S., Kahn N.N., and Sinha A.K. Purification and properties of insulin-activated nitric oxide synthase from human erythrocyte membranes. Arch Physiol Biochem 109 (2001) 441-449
32. In: Gove P.B., Artin E., Bethel J.P., Cook D., Driscoll A.M., Goepp P.H., et al. (Eds). 1986. Webster's Third New International Dictionary (1986), Merriam-Webster, Inc, Publishers, Springfield, Massachusetts